• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Rho激酶抑制剂盐酸水合物(K-115)对兔眼血流及睫状动脉平滑肌收缩的影响。

Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.

作者信息

Ohta Yusuke, Takaseki Sanae, Yoshitomi Takeshi

机构信息

Department of Ophthalmology, Akita University School of Medicine, 1-1-1 Hondo, Akita, Akita, 010-8543, Japan.

出版信息

Jpn J Ophthalmol. 2017 Sep;61(5):423-432. doi: 10.1007/s10384-017-0524-y. Epub 2017 Jun 26.

DOI:10.1007/s10384-017-0524-y
PMID:28653193
Abstract

PURPOSE

Ripasudil, a Rho-associated coiled-coil-containing protein kinase (ROCK) inhibitor, is a novel drug for glaucoma in Japan. ROCK inhibition not only reduces intraocular pressure (IOP) but also increases ocular blood flow. We investigated the effects of ripasudil on optic disc blood flow (ODBF) in rabbit eyes and in isolated rabbit ciliary arteries.

METHODS

We measured IOP by tonometry and ODBF by laser speckle flowgraphy (LSFG) in male Dutch rabbits. A single drop (20 μL) of 0.8% ripasudil was delivered to the ocular surface after topical application of phenylephrine hydrochloride to reduce the ODBF. The effects of ripasudil on isolated rabbit ciliary artery smooth muscle contractions were measured in vitro with a myograph.

RESULTS

Ripasudil inhibited the reduction of ODBF induced by phenylephrine at 30 and 120 min after instillation (P < .05). The blood flow change was not significantly correlated with the IOP change. Ripasudil induced a concentration-dependent relaxation in isolated rabbit ciliary arteries precontracted with a high-potassium solution. This relaxation was not mediated through the endothelium-dependent activities of nitric oxide synthase, prostacyclin, or the large-conductance calcium-activated K channel as shown by the inability of specific inhibitors of these pathways to block the ripasudil-induced relaxation.

CONCLUSIONS

Taken together, our results showed that ripasudil not only decreased IOP but also increased ODBF in rabbits. However, the changes in IOP were not correlated with the changes in ODBF. Ripasudil also induced a concentration-dependent relaxation of isolated rabbit ciliary arteries through a NO-independent mechanism. Further investigation of the effect of ripasudil on ODBF is needed.

摘要

目的

ripasudil是一种Rho相关卷曲螺旋蛋白激酶(ROCK)抑制剂,在日本是一种治疗青光眼的新型药物。ROCK抑制不仅可降低眼压(IOP),还可增加眼部血流量。我们研究了ripasudil对兔眼和离体兔睫状动脉视盘血流量(ODBF)的影响。

方法

我们通过眼压测量法测量雄性荷兰兔的IOP,并通过激光散斑血流图(LSFG)测量ODBF。在局部应用盐酸去氧肾上腺素以降低ODBF后,将一滴(20μL)0.8%的ripasudil滴于眼表。在体外使用肌动描记器测量ripasudil对离体兔睫状动脉平滑肌收缩的影响。

结果

ripasudil在滴注后30分钟和120分钟时抑制了去氧肾上腺素诱导的ODBF降低(P<0.05)。血流量变化与IOP变化无显著相关性。ripasudil在高钾溶液预收缩的离体兔睫状动脉中诱导浓度依赖性舒张。如这些途径的特异性抑制剂无法阻断ripasudil诱导的舒张所示,这种舒张不是通过一氧化氮合酶、前列环素或大电导钙激活钾通道的内皮依赖性活性介导的。

结论

综上所述,我们的结果表明ripasudil不仅降低了兔的IOP,还增加了ODBF。然而,IOP的变化与ODBF的变化无关。ripasudil还通过非一氧化氮依赖性机制诱导离体兔睫状动脉浓度依赖性舒张。需要进一步研究ripasudil对ODBF的影响。

相似文献

1
Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits.Rho激酶抑制剂盐酸水合物(K-115)对兔眼血流及睫状动脉平滑肌收缩的影响。
Jpn J Ophthalmol. 2017 Sep;61(5):423-432. doi: 10.1007/s10384-017-0524-y. Epub 2017 Jun 26.
2
Vasodilatory effect of L-arginine on isolated rabbit and human posterior ciliary arteries in vitro and increased optic disc blood flow in vivo.L-精氨酸对离体兔和人睫状后动脉的血管舒张作用及对活体视盘血流的增加作用。
Graefes Arch Clin Exp Ophthalmol. 2017 Dec;255(12):2381-2388. doi: 10.1007/s00417-017-3824-5. Epub 2017 Oct 23.
3
Effects of ripasudil, a rho kinase inhibitor, on blood flow in the optic nerve head of normal rats.Rho激酶抑制剂法舒地尔对正常大鼠视神经乳头血流的影响。
Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):303-311. doi: 10.1007/s00417-018-4191-6. Epub 2018 Nov 24.
4
Additive intraocular pressure-lowering effects of the Rho kinase inhibitor ripasudil in Japanese patients with various subtypes of glaucoma.Rho激酶抑制剂ripasudil对日本不同亚型青光眼患者的眼压降低具有相加作用。
Jpn J Ophthalmol. 2019 Jan;63(1):40-45. doi: 10.1007/s10384-018-0635-0. Epub 2018 Oct 28.
5
Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine.通过滴注ROCK抑制剂力法舒地尔增加光学相干断层扫描血管造影术检测的视乳头周围血管密度:与溴莫尼定的比较
Graefes Arch Clin Exp Ophthalmol. 2018 Jul;256(7):1257-1264. doi: 10.1007/s00417-018-3945-5. Epub 2018 Mar 8.
6
Effects of Rho-associated protein kinase inhibitors Y-27632 and Y-39983 on isolated rabbit ciliary arteries.Rho 相关蛋白激酶抑制剂 Y-27632 和 Y-39983 对兔离体睫状动脉的作用。
Jpn J Ophthalmol. 2011 Jul;55(4):411-417. doi: 10.1007/s10384-011-0048-9. Epub 2011 Jun 11.
7
Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma.Rho相关激酶抑制剂法舒地尔治疗葡萄膜炎性青光眼的疗效和安全性
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):809-814. doi: 10.1007/s00417-018-3933-9. Epub 2018 Feb 21.
8
Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing.Rho相关激酶抑制剂滴眼液(丽科明)对角膜内皮伤口愈合的影响。
Invest Ophthalmol Vis Sci. 2016 Mar;57(3):1284-92. doi: 10.1167/iovs.15-18586.
9
Ripasudil hydrochloride hydrate: targeting Rho kinase in the treatment of glaucoma.盐酸水合瑞帕舒迪:靶向Rho激酶治疗青光眼。
Expert Opin Pharmacother. 2017 Oct;18(15):1669-1673. doi: 10.1080/14656566.2017.1378344. Epub 2017 Sep 14.
10
Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.Rho激酶抑制剂K-115对兔眼房水动力学的影响。
Curr Eye Res. 2014 Aug;39(8):813-22. doi: 10.3109/02713683.2013.874444. Epub 2014 Feb 6.

引用本文的文献

1
Neuroprotective effect of ripasudil on retinal ganglion cells via an antioxidative mechanism.ripasudil通过抗氧化机制对视网膜神经节细胞的神经保护作用。
Jpn J Ophthalmol. 2025 Jul 2. doi: 10.1007/s10384-025-01243-x.
2
Rho Kinase (ROCK) Inhibitors in the Treatment of Glaucoma and Glaucoma Surgery: A Systematic Review of Early to Late Phase Clinical Trials.Rho激酶(ROCK)抑制剂在青光眼及青光眼手术治疗中的应用:早期至晚期临床试验的系统评价
Pharmaceuticals (Basel). 2025 Apr 3;18(4):523. doi: 10.3390/ph18040523.
3
Rho Kinase Inhibitors in Glaucoma Management: Current Perspectives and Future Directions.

本文引用的文献

1
Ocular Penetration and Pharmacokinetics of Ripasudil Following Topical Administration to Rabbits.兔局部应用力法舒地尔的眼内通透性和药代动力学
J Ocul Pharmacol Ther. 2016 Sep;32(7):405-14. doi: 10.1089/jop.2016.0028. Epub 2016 Jul 27.
2
Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells.新型ROCK抑制剂K-115(ripasudil)对小梁网和施莱姆管内皮细胞的作用。
Sci Rep. 2016 Jan 19;6:19640. doi: 10.1038/srep19640.
3
One-year clinical evaluation of 0.4% ripasudil (K-115) in patients with open-angle glaucoma and ocular hypertension.
Rho激酶抑制剂在青光眼治疗中的应用:当前观点与未来方向
Drug Des Devel Ther. 2025 Apr 2;19:2519-2531. doi: 10.2147/DDDT.S515166. eCollection 2025.
4
Advances in Neuroprotection in Glaucoma: Pharmacological Strategies and Emerging Technologies.青光眼神经保护的进展:药理学策略与新兴技术
Pharmaceuticals (Basel). 2024 Sep 25;17(10):1261. doi: 10.3390/ph17101261.
5
Electroacupuncture improves retinal function in myopia Guinea pigs probably via inhibition of the RhoA/ROCK2 signaling pathway.电针可能通过抑制RhoA/ROCK2信号通路改善近视豚鼠的视网膜功能。
Heliyon. 2024 Aug 5;10(15):e35750. doi: 10.1016/j.heliyon.2024.e35750. eCollection 2024 Aug 15.
6
The Application of Rho Kinase Inhibitors in the Management of Glaucoma.Rho 激酶抑制剂在青光眼治疗中的应用。
Int J Mol Sci. 2024 May 21;25(11):5576. doi: 10.3390/ijms25115576.
7
Rho-Kinase Inhibitors as Emerging Targets for Glaucoma Therapy.Rho激酶抑制剂作为青光眼治疗的新兴靶点。
Ophthalmol Ther. 2023 Dec;12(6):2943-2957. doi: 10.1007/s40123-023-00820-y. Epub 2023 Oct 14.
8
Rho-kinase Inhibitors in Ocular Diseases: A Translational Research Journey.眼科疾病中的 Rho 激酶抑制剂:一段转化研究历程
J Curr Glaucoma Pract. 2023 Jan-Mar;17(1):44-48. doi: 10.5005/jp-journals-10078-1396.
9
Newer advances in medical management of glaucoma.青光眼的医学管理新进展。
Indian J Ophthalmol. 2022 Jun;70(6):1920-1930. doi: 10.4103/ijo.IJO_2239_21.
10
Neuroprotection in glaucoma.青光眼的神经保护。
Indian J Ophthalmol. 2022 Feb;70(2):380-385. doi: 10.4103/ijo.IJO_1158_21.
0.4% 利马前列素(K-115)治疗开角型青光眼和高眼压症患者的一年临床评估
Acta Ophthalmol. 2016 Feb;94(1):e26-34. doi: 10.1111/aos.12829. Epub 2015 Sep 4.
4
Effect of intravitreal Rho kinase inhibitor ripasudil (K-115) on feline retinal microcirculation.玻璃体内注射Rho激酶抑制剂法舒地尔(K-115)对猫视网膜微循环的影响。
Exp Eye Res. 2015 Oct;139:132-5. doi: 10.1016/j.exer.2015.07.008. Epub 2015 Jul 18.
5
Towards axonal regeneration and neuroprotection in glaucoma: Rho kinase inhibitors as promising therapeutics.青光眼轴突再生和神经保护的研究进展:Rho 激酶抑制剂作为有前途的治疗药物。
Prog Neurobiol. 2015 Aug;131:105-19. doi: 10.1016/j.pneurobio.2015.06.002. Epub 2015 Jun 17.
6
Additive Intraocular Pressure-Lowering Effects of the Rho Kinase Inhibitor Ripasudil (K-115) Combined With Timolol or Latanoprost: A Report of 2 Randomized Clinical Trials.Rho 激酶抑制剂 ripasudil(K-115)联合噻吗洛尔或拉坦前列素的降眼压相加作用:两项随机临床试验报告。
JAMA Ophthalmol. 2015 Jul;133(7):755-61. doi: 10.1001/jamaophthalmol.2015.0525.
7
Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study.Rho激酶抑制剂法舒地尔(K-115)对原发性开角型青光眼和高眼压症患者24小时眼压降低作用的随机、开放标签、交叉研究
Acta Ophthalmol. 2015 Jun;93(4):e254-60. doi: 10.1111/aos.12599. Epub 2014 Dec 9.
8
Ripasudil: first global approval.利匹司他:全球首次批准。
Drugs. 2014 Dec;74(18):2211-5. doi: 10.1007/s40265-014-0333-2.
9
Validation of rebound tonometry for intraocular pressure measurement in the rabbit.兔眼眼压回弹测量的验证。
Exp Eye Res. 2014 Apr;121:86-93. doi: 10.1016/j.exer.2014.02.004. Epub 2014 Feb 20.
10
Effects of K-115, a rho-kinase inhibitor, on aqueous humor dynamics in rabbits.Rho激酶抑制剂K-115对兔眼房水动力学的影响。
Curr Eye Res. 2014 Aug;39(8):813-22. doi: 10.3109/02713683.2013.874444. Epub 2014 Feb 6.